Aptorum completes merger with DiamiR, redomiciles as Niki BioSolutions, trades under NIKI

Aptorum Group Ltd

Merger closed July 20, 2026; Aptorum redomiciled to Delaware and renamed Niki BioSolutions, Inc.
DiamiR shareholders received ~1.98M shares of Niki common; Aptorum shareholders got ~814K common and ~180K Series A preferred.
1-for-10 reverse stock split effective July 20, reducing outstanding Class A from ~6.35M to ~635K shares.
New board: Ian Huen (Chairman), Kira Sheinerman, Justin Wu, Douglas Arner, Laura A. Philips, Alidad Mireskandari (observer).
Adopted 2026 Incentive Plan reserving 4.5M shares plus annual evergreen increases.

item 2.01 item 3.03 item 5.02 item 5.03 item 8.01 item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.